BOT 0.00% 34.5¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-657

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 324 Posts.
    lightbulb Created with Sketch. 91
    Has anyone stopped to consider that the three days of TH was to craft the release in a way that was carefully governed by the ASX to ensure it read a certain way and to ensure no exuberant language to maintain regulatory compliance? Reality is the results must be released in accordance with guidelines and cannot spruik. The can say they are pleased but that’s about it. Fact based reporting is all that’s allowed the. It’s up to the market to decide the price.

    if the company wants to address the sell off, the engage brokers and the media is likely the best shot, but even so, they must be cautious not to over step. End of the day, the results met the trial end point. If the end point of the 2A is meaningless, then that’s another issue and why the rally into it? None of this really makes sense to me Tbh.

    The results are factually accurate and were disclosed as such, supported with unarguable numeric data. As far as I can tell meeting the primary school end point is not open to interpretation ... it was met.

    it’s up to investors now to interpret the results and if this sell off is fundamental (I think it’s technical) meaning that results did suck, then I’m stumped and open to a fact based explanation, not a cryptic conspiracy theory about the ‘words they used’.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.